ETON Sale Disclosure
Brynjelsen Sean · SEC Form 4 · Filed Aug 20, 2026
Sale
Calculated transaction value
$2.85M
Brynjelsen Sean President & CEO
ETON
Eton Pharmaceutcials
ETON
Transaction date
Aug 20, 2026
Public filing date
Aug 20, 2026
Filing lag
Filed same day
ETON daily price context
Close on/before transaction
$59.91
Aug 20, 2026
Close before public filing
$61.48
Aug 19, 2026
Return since public filing
-8.34%
Through Sep 16, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 47,307 shares @ $60.17
- SEC ownership
- Direct
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001437749-26-028651
Filing cohort
Transactions in this filing
Showing 4 of 4
Trades
4
Issuers
1
Estimated value
$6.09M
Buys / sales
0 / 4
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Eton Pharmaceuticals, Inc. ETON Current | Sale | Aug 20, 2026 | $2.85M |
| Eton Pharmaceuticals, Inc. ETON | Sale | Aug 20, 2026 | $2.22M |
| Eton Pharmaceuticals, Inc. ETON | Sale | Aug 20, 2026 | $456.09K |
| Eton Pharmaceuticals, Inc. ETON | Sale | Aug 19, 2026 | $562.47K |